|
1.
|
Saito H, Frleta D, Dubsky P and Palucka
AK: Dendritic cell-based vaccination against cancer. Hematol Oncol
Clin North Am. 20:689–710. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Dou J, Chu LL, Zhao FS, et al: Study of
immunotherapy of murine myeloma by an IL-21-based tumor vaccine in
Balb/c mice. Cancer Biol Ther. 6:1871–1879. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Chunyu C, Han Yu, Yushan R and Yanlin W:
Mitoxantrone-mediated apoptotic B16-F1 cells induce specific
anti-tumor immune response. Cell Mol Immunol. 6:469–475. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Obeid M, Tesniere A, Ghiringhelli F, et
al: Calreticulin exposure dictates the immunogenicity of cancer
cell death. Nat Med. 13:54–61. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Mimeault M, Hauke R, Mehta PP, et al:
Recent advances in cancer stem/progenitor cell research:
therapeutic implications for overcoming resistance to the most
aggressive cancers. J Cell Mol Med. 11:981–1011. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
An Y and Ongkeko WM: ABCG2: the key to
chemoresistance in cancer stem cells? Expert Opin Drug Metab
Toxicol. 5:1529–1542. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Schinkel AH and Jonker JW: Mammalian drug
efflux transporters of the ATP binding cassette (ABC) family: an
overview. Advanced Drug Delivery Rev. 55:3–29. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Van Veen HW, Venema K, Bolhuis H, et al:
Multidrug resistance mediated by a bacterial homolog of the human
multidrug transporter MDR1. Proc Natl Acad Sci USA. 93:10668–10672.
1996.PubMed/NCBI
|
|
9.
|
Droi S, Eytan GD and Assaraf YG:
Potentiation of anticancer-drug cytotoxicity by
multidrug-resistance chemosensitizers involves alterations in
membrane fluidity leading to increased membrane permeability. Eur J
Biochem. 228:1020–1029. 1995. View Article : Google Scholar
|
|
10.
|
Spengler G, Viveiros M, Martins M, et al:
Demonstration of the activity of P-glycoprotein by a semi-automated
fluorometric method. Anticancer Res. 29:2173–2177. 2009.PubMed/NCBI
|
|
11.
|
Fengshu Z, Jun D, XiangFeng H, et al:
Enhancing therapy of B16F10 melanoma efficacy through tumor vaccine
expressing GPI-anchored IL-21 and secreting GM-CSF in mouse model.
Vaccine. 28:2846–2852. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Hyesung K, Hyemi P, Jungsun P, et al:
Dendritic cell vaccine in addition to FOLFIRI regimen improve
antitumor effects through the inhibition of immunosuppressive cells
in murine colorectal cancer model. Vaccine. 28:7787–7796. 2010.
View Article : Google Scholar
|
|
13.
|
Groh V, Steinle A, Spies T, et al:
Recognition of stress-induced MHC molecules by intestinal
epithelial gammadelta T cells. Science. 279:1737–1740. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Jun D, Yongfang W, Jing W, et al:
Antitumor efficacy induced by human ovarian cancer cells secreting
IL-21 alone or combination with GM-CSF cytokines in nude mice
model. Immunobiology. 214:483–492. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Jun D, Quan T, Fengshu Z, et al:
Comparison of immune responses induced in mice by vaccination with
DNA vaccine constructs expressing mycobacterial antigen 85A &
interleukin-21 and Bacillus Galmette-Guérin. Immunol Invest.
37:113–127. 2008.PubMed/NCBI
|
|
16.
|
Dou J, Wen P, Hu W, et al: Identifying
tumor stem-like cells in mouse melanoma cell lines by analyzing the
characteristics of side population cells. Cell Biol Int.
33:807–815. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Karla PK, Earla R, Boddu SH, et al:
Molecular expression and functional evidence of a drug efflux pump
(BCRP) in human corneal epithelial cells. Curr Eye Res. 34:1–9.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Yuan JH, He ZM, Yu YH, et al: Expression
establishment and functional analysis of breast cancer resistance
protein with doxycycline induced tet regulating system in mouse
fibroblast cell line PA317. Ai Zheng. 23:1127–1133. 2004.
|
|
19.
|
Lecoeur H, Février M, Garcia S, Rivière Y
and Gougeon ML: A novel flow cytometric assay for quantitation and
multiparametric characterization of cell-mediated cytotoxicity. J
Immunol Methods. 253:177–187. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Fengshu Z, Jun D, Wang J, et al:
Investigation on the anti-tumor efficacy by expression of
GPI-anchored mIL-21 on the surface of B16F10 cells in C57BL/6 mice.
Immunobiology. 215:89–100. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Goodell MA, Brose K, Paradis G, et al:
Isolation and functional properties of murine hematopoietic stem
cells that are replicating in vivo. J Exp Med. 183:1797–1806. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Jun D and Ning G: Emerging strategies for
the identification and targeting of cancer stem cells. Tumor Bio.
31:243–253. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Frank MO, Kaufman J, Tian S, et al:
Harnessing naturally occurring tumor immunity: a clinical vaccine
trial in prostate cancer. PLoS One. 5:e123672010. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Taniguchi K, Nishiura H, Ota Y, et al:
Roles of the ribosomal protein S19 dimer and chemically induced
apoptotic cells as a tumor vaccine in syngeneic mouse
transplantation models. J Immunother. 34:16–27. 2011. View Article : Google Scholar
|
|
25.
|
Banchereau J and Steinman R: Dendritic
cells and the control of immunity. Nature. 392:245–152. 1998.
View Article : Google Scholar
|
|
26.
|
Gardai SJ, McPhillips KA, Frasch SC, et
al: Cell-surface calreticulin initiates clearance of viable or
apoptotic cells through trans-activation of LRP on the phagocyte.
Cell. 123:321–334. 2005. View Article : Google Scholar
|
|
27.
|
Hu W, Wang J, Dou J, et al: Augmenting
therapy of ovarian cancer efficacy by secreting IL-21 human
umbilical cord blood stem cells in nude mice. Cell Transplant. Nov
5–2010.(E-pub ahead of print).
|
|
28.
|
Panaretakis T, Joza N, Modjtahedi N, et
al: The co-translocation of ERp57 and calreticulin determines the
immunogenicity of cell death. Cell Death Differ. 15:1499–1509.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Davide B, Stefano G, Giovanna C, et al:
Post-apoptotic tumors are more palatable to dendritic cells and
enhance their antigen cross-presentation activity. Vaccine.
26:6422–6432. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Palucka AK, Ueno H, Fay JW, et al: Taming
cancer by inducing immunity via dendritic cells. Immunol Rev.
220:129–150. 2007. View Article : Google Scholar : PubMed/NCBI
|
